Prognostic value of aggregate index of systemic inflammation in acute ischemic stroke mortality
Open Access
- 30 June 2025
- journal article
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- Vol. 16 (2) , 276-282
Abstract
Aim: Systemic inflammation plays a key role in the pathophysiology of acute ischemic stroke (AIS), influencing disease severity and outcomes. The Aggregate Index of Systemic Inflammation (AISI) is a novel inflammatory biomarker that integrates multiple hematological parameters. This study aimed to evaluate the prognostic value of AISI in predicting 30-day mortality in AIS patients. Material and Methods: This retrospective cohort study included patients diagnosed with AIS in the emergency department of a tertiary care hospital between January 1, 2022, and January 1, 2025. AISI was calculated as (Neutrophil count × Monocyte count × Platelet count) / Lymphocyte count, with all components expressed in absolute values (×10⁹/L). The primary outcome was 30-day all-cause mortality. Logistic regression analysis was performed to assess the independent prognostic value of AISI. Model performance was evaluated using accuracy, sensitivity, specificity, and the area under the receiver operating characteristic curve (AUROC). Results: A total of 663 AIS patients were analyzed, including 573 survivors (86.4%) and 90 non-survivors (13.6%). AISI values were significantly higher in non-survivors compared to survivors (755.4 ± 410.8 vs. 396.7 ± 216.1, p < 0.001). Multivariate logistic regression analysis identified AISI as an independent predictor of 30-day mortality (OR: 1.10, 95% CI: 1.02–1.19, p = 0.040). The AUROC for AISI was 0.820, indicating good discriminatory ability. Conclusions: AISI was found to be an independent predictor of 30-day mortality in AIS patients, highlighting the potential role of systemic inflammation in stroke prognosis. Given its accessibility and ease of calculation, AISI could serve as a useful marker for early risk stratification in clinical practice. However, further prospective, multicenter studies are needed to validate its clinical utility and compare it with other established inflammatory indices.Keywords
Funding Information
- he authors received no financial support for the research and/or authorship of this article.
This publication has 18 references indexed in Scilit:
- Global, regional, and national epidemiology of ischemic stroke from 1990 to 2021European Journal of Neurology, 2024
- Advancing stroke therapy: A deep dive into early phase of ischemic stroke and recanalizationCNS Neuroscience & Therapeutics, 2024
- Hemorrhagic Conversion of Acute Ischemic StrokeNeurotherapeutics, 2023
- Aggregate index of systemic inflammation (AISI) in admission as a reliable predictor of mortality in COPD patients with COVID-19BMC Pulmonary Medicine, 2023
- Inflammatory Responses After Ischemic StrokeSeminars in Immunopathology, 2022
- Immune Pathways in Etiology, Acute Phase, and Chronic Sequelae of Ischemic StrokeCirculation Research, 2022
- Admission blood lactate levels of patients diagnosed with cerebrovascular disease effects on short‐ and long‐term mortality riskInternational Journal Of Clinical Practice, 2021
- Blood Cell Count Derived Inflammation Indexes in Patients with Idiopathic Pulmonary FibrosisLung, 2020
- Global Stroke Statistics 2019International Journal of Stroke, 2020
- Neuroinflammation: friend and foe for ischemic strokeJournal of Neuroinflammation, 2019